Decade Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
PC
WRF
Decade Capital Management's TEVA Position: Q3 2015 in Review
Decade Capital Management opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2015: 17,302 shares worth $977K. The stake represents 0.21% of the portfolio and ranks #83 among its holdings. This is a return to the name: Decade Capital Management previously reported a position in TEVA as recently as Q4 2014.
Decade Capital Management first reported a position in TEVA in Q4 2014 and has held it in 2 quarters since. The position peaked at $4.31M in Q4 2014. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.
- Decade Capital Management held 17,302 shares of Teva Pharmaceuticals worth $977K as of Q3 2015.
- Teva Pharmaceuticals was a new Decade Capital Management position in Q3 2015.
- Teva Pharmaceuticals made up 0.21% of Decade Capital Management's portfolio in Q3 2015, its #83 holding.
- Decade Capital Management first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 2 quarters since.
- Decade Capital Management's Teva Pharmaceuticals position peaked at $4.31M in Q4 2014.
- 823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.
Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.